199 related articles for article (PubMed ID: 28718500)
1. Neurofilament light as an immune target for pathogenic antibodies.
Puentes F; van der Star BJ; Boomkamp SD; Kipp M; Boon L; Bosca I; Raffel J; Gnanapavan S; van der Valk P; Stephenson J; Barnett SC; Baker D; Amor S
Immunology; 2017 Dec; 152(4):580-588. PubMed ID: 28718500
[TBL] [Abstract][Full Text] [Related]
2. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
Khan RS; Dine K; Luna E; Ahlem C; Shindler KS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5744-51. PubMed ID: 25139738
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.
Shindler KS; Ventura E; Dutt M; Rostami A
Exp Eye Res; 2008 Sep; 87(3):208-13. PubMed ID: 18653182
[TBL] [Abstract][Full Text] [Related]
4. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
5. Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Puentes F; van der Star BJ; Victor M; Kipp M; Beyer C; Peferoen-Baert R; Ummenthum K; Pryce G; Gerritsen W; Huizinga R; Reijerkerk A; van der Valk P; Baker D; Amor S
J Neuroinflammation; 2013 Sep; 10():118. PubMed ID: 24053384
[TBL] [Abstract][Full Text] [Related]
6. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
Huizinga R; Gerritsen W; Heijmans N; Amor S
Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
[TBL] [Abstract][Full Text] [Related]
7. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
8. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
9. Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Brambilla R; Dvoriantchikova G; Barakat D; Ivanov D; Bethea JR; Shestopalov VI
J Neuroinflammation; 2012 Sep; 9():213. PubMed ID: 22963651
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 activation confers neuroprotection in experimental optic neuritis.
Shindler KS; Ventura E; Rex TS; Elliott P; Rostami A
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3602-9. PubMed ID: 17652729
[TBL] [Abstract][Full Text] [Related]
11. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
Larabee CM; Hu Y; Desai S; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():332-41. PubMed ID: 27122964
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
[TBL] [Abstract][Full Text] [Related]
13. Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.
Manogaran P; Samardzija M; Schad AN; Wicki CA; Walker-Egger C; Rudin M; Grimm C; Schippling S
Acta Neuropathol Commun; 2019 Jul; 7(1):116. PubMed ID: 31315675
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Adamus G; Brown L; Andrew S; Meza-Romero R; Burrows GG; Vandenbark AA
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):406-12. PubMed ID: 22167100
[TBL] [Abstract][Full Text] [Related]
15. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.
Guan Y; Shindler KS; Tabuena P; Rostami AM
J Neuroimmunol; 2006 Sep; 178(1-2):40-8. PubMed ID: 16828169
[TBL] [Abstract][Full Text] [Related]
16. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
[TBL] [Abstract][Full Text] [Related]
17. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers.
McKeon A; Shelly S; Zivelonghi C; Basal E; Dubey D; Flanagan E; Madhavan AA; Mariotto S; Toledano M; Tracy JA; Zekeridou A; Pittock SJ
Ann Clin Transl Neurol; 2021 Feb; 8(2):425-439. PubMed ID: 33369283
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
Modvig S; Degn M; Sander B; Horwitz H; Wanscher B; Sellebjerg F; Frederiksen JL
Mult Scler; 2016 Apr; 22(5):590-8. PubMed ID: 26283696
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis.
Gnanapavan S; Grant D; Pryce G; Jackson S; Baker D; Giovannoni G
Autoimmunity; 2012 Jun; 45(4):298-303. PubMed ID: 22276904
[TBL] [Abstract][Full Text] [Related]
20. Exploring experimental autoimmune optic neuritis using multimodal imaging.
Manogaran P; Walker-Egger C; Samardzija M; Waschkies C; Grimm C; Rudin M; Schippling S
Neuroimage; 2018 Jul; 175():327-339. PubMed ID: 29627590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
